2016
DOI: 10.1038/srep29317
|View full text |Cite
|
Sign up to set email alerts
|

Rosette-Disrupting Effect of an Anti-Plasmodial Compound for the Potential Treatment of Plasmodium falciparum Malaria Complications

Abstract: The spread of artemisinin-resistant parasites could lead to higher incidence of patients with malaria complications. However, there are no current treatments that directly dislodge sequestered parasites from the microvasculature. We show that four common antiplasmodial drugs do not disperse rosettes (erythrocyte clusters formed by malaria parasites) and therefore develop a cell-based high-throughput assay to identify potential rosette-disrupting compounds. A pilot screen of 2693 compounds identified Malaria Bo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 19 publications
(24 citation statements)
references
References 33 publications
0
24
0
Order By: Relevance
“…falciparum . Future studies should strive to understand the pathobiological process behind non-falciparum and possible develop therapeutics that disrupt their formation[ 27 , 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…falciparum . Future studies should strive to understand the pathobiological process behind non-falciparum and possible develop therapeutics that disrupt their formation[ 27 , 28 ].…”
Section: Discussionmentioning
confidence: 99%
“…30 µl of stained cells were added to 150 µl PBS in 96-well plates and analysed by BD FACSVerse flow cytometer. FITC levels of trophozoite-infected cells were measured after sequential gating as described elsewhere 51 , with only singlet events being measured. GFP+ cells were defined as all events that generated FITC signals above the untransfected NF54 parasites.…”
Section: Methodsmentioning
confidence: 99%
“…A, B or AB) patients show higher levels of rosetting than isolates from group O patients in studies from sub-Saharan Africa (Rowe et al ., 1995, 2007) and India (Rout et al ., 2012), although the same result was not seen in one Thai study (Lee et al ., 2014). When parasites are cultured in their ‘preferred’ blood group, they form larger, stronger rosettes that are more resistant to disruption by antibodies or chemical agents than in group O cells (Carlson and Wahlgren, 1992; Barragan et al ., 2000 b ; Ch'ng et al ., 2016). Enzymatic removal of the terminal sugars ( N -acetyl-D-galactosamine for A and D-galactose for B) results in smaller, weaker rosettes, equivalent to those seen in group O erythrocytes (Barragan et al ., 2000 b ).…”
Section: Rosetting Receptors On Host Erythrocytesmentioning
confidence: 99%